Contact
searchSearch
HMP Global

May 2015 - FRMC

CMRs May Reduce Hospitalizations and Pharmacy Costs
06/10/2015
Data has shown that medication therapy management (MTM) can improve patient outcomes. MTMs can be deployed by several av- enues including internal teams at health plans, retail pharmacy, and third-party MTM companies.
Data has shown that medication therapy management (MTM) can improve patient outcomes. MTMs can be deployed by several av- enues including internal teams at health plans, retail pharmacy, and third-party MTM companies.
Data has shown that medication...
06/10/2015
First Report Managed Care
New Versus Old Injectable Antipsychotics for Schizophrenia
06/10/2015
Long-acting injectable (LAI) antipsychotics are highly effective in the management of schizophrenia and associated with a number of potential advantages over oral antipsychotics. First-generation LAIs (LA1s) have been available for more than...
Long-acting injectable (LAI) antipsychotics are highly effective in the management of schizophrenia and associated with a number of potential advantages over oral antipsychotics. First-generation LAIs (LA1s) have been available for more than...
Long-acting injectable (LAI)...
06/10/2015
First Report Managed Care
Cost-Effectiveness of 6 Therapies for RRMS
06/10/2015
Multiple sclerosis is an unpredictable, disabling disease with no known cure. Several disease-modifying treatments exist to reduce disease activity and progression.
Multiple sclerosis is an unpredictable, disabling disease with no known cure. Several disease-modifying treatments exist to reduce disease activity and progression.
Multiple sclerosis is an...
06/10/2015
First Report Managed Care
Study Finds Injectable versus Infusion Biologics Less Costly
06/10/2015
Autoimmune disorder patients taking injectable biologics had lower average monthly drug costs compared to patients taking infusion biologics, according to the results of a new study.
Autoimmune disorder patients taking injectable biologics had lower average monthly drug costs compared to patients taking infusion biologics, according to the results of a new study.
Autoimmune disorder patients...
06/10/2015
First Report Managed Care
Potential New Cystic Fibrosis Treatment Could Raise Costs
06/10/2015
New drugs on the horizon for cystic fibrosis (CF) could result in better patient outcomes, but will likely come at a higher cost, according to a poster session at AMCP titled Cystic Fibrosis Prevalence and Total Cost of Care in a Commercially...
New drugs on the horizon for cystic fibrosis (CF) could result in better patient outcomes, but will likely come at a higher cost, according to a poster session at AMCP titled Cystic Fibrosis Prevalence and Total Cost of Care in a Commercially...
New drugs on the horizon for...
06/10/2015
First Report Managed Care

Department

Conference Insider
Clinical Prior Authorization Edit Curbs Costs for ADD/ADHD Population in Fee-For-Service Arrangements
06/10/2015
A new study examining the impact of a recently implemented clinical prior authorization edit for attention deficit disorder (ADD) and attention deficit/hyperactivity disorder (ADHD) found that the edit costs increased at a significantly lower...
A new study examining the impact of a recently implemented clinical prior authorization edit for attention deficit disorder (ADD) and attention deficit/hyperactivity disorder (ADHD) found that the edit costs increased at a significantly lower...
A new study examining the impact...
06/10/2015
First Report Managed Care
Conference Insider
Treating Patients with Relapsing MS
06/10/2015
Multiple sclerosis (MS) is an autoimmune disease in which the immune system attacks the protective layer around nerves. During a science and innovation theater at AMCP, Lilly Jung Henson, MD, MMM, FAAN, director of the neurology clinic, Swed-...
Multiple sclerosis (MS) is an autoimmune disease in which the immune system attacks the protective layer around nerves. During a science and innovation theater at AMCP, Lilly Jung Henson, MD, MMM, FAAN, director of the neurology clinic, Swed-...
Multiple sclerosis (MS) is an...
06/10/2015
First Report Managed Care
Conference Insider
Obstacles in the Pursuit of Optimal Hyperkalemia Management
06/10/2015
Hyperkalemia is a condition in which potassium levels in the blood are elevated due to decreased kidney function. This condition is extremely common among Medicare-aged patients with chronic kidney disease (CKD) and heart failure (HF).
Hyperkalemia is a condition in which potassium levels in the blood are elevated due to decreased kidney function. This condition is extremely common among Medicare-aged patients with chronic kidney disease (CKD) and heart failure (HF).
Hyperkalemia is a condition in...
06/10/2015
First Report Managed Care
Conference Insider
Targeting Very High Triglycerides in At-Risk Patients
06/10/2015
Hypertriglyceridemia is elevated triglyceride concentration in the blood caused by genetics, obesity, medications, and acute alcohol use with fatty liver disease.
Hypertriglyceridemia is elevated triglyceride concentration in the blood caused by genetics, obesity, medications, and acute alcohol use with fatty liver disease.
Hypertriglyceridemia is elevated...
06/10/2015
First Report Managed Care

News

News
Managing Heart Failure
06/10/2015
Heart failure (HF) is the leading cause of rehospitalization in both men and women on Medicare and the underlying cause of >58,000 US deaths in 2011, according to the Centers for Disease Control and Prevention.
Heart failure (HF) is the leading cause of rehospitalization in both men and women on Medicare and the underlying cause of >58,000 US deaths in 2011, according to the Centers for Disease Control and Prevention.
Heart failure (HF) is the...
06/10/2015
First Report Managed Care
FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

What's Trending?

News
Study Analyzes Health Technology Assessment Decisions for Pain Therapies
06/17/2019
Researchers presented data uncovered during an evaluation of health technology assessment decisions and rationale and found that many new pain therapies are rejected due to lack of demonstrated benefits.
Researchers presented data uncovered during an evaluation of health technology assessment decisions and rationale and found that many new pain therapies are rejected due to lack of demonstrated benefits.
Researchers presented data...
06/17/2019
First Report Managed Care
News
U.S. Rebukes Health Insurers
09/10/2010
09/10/2010
First Report Managed Care
News
Brands Over Generics: Some Formularies Break The Golden Rule
10/26/2017
Some formularies are pushing patients away from cheaper generics in favor of high cost generics. We spoke with some managed care experts to understand why this practice is in place for some insurers.
Some formularies are pushing patients away from cheaper generics in favor of high cost generics. We spoke with some managed care experts to understand why this practice is in place for some insurers.
Some formularies are pushing...
10/26/2017
First Report Managed Care
News
Prepectoral Edema Suggests Malignant Breast Tumor
04/06/2015
Prepectoral edema on magnetic resonance mammography (MRM) strongly suggests the presence of malignant breast tumors.
Prepectoral edema on magnetic resonance mammography (MRM) strongly suggests the presence of malignant breast tumors.
Prepectoral edema on magnetic...
04/06/2015
First Report Managed Care
Conference Insider
What’s Happening at ISPOR 2019?
05/17/2019
During ISPOR 2019, more than 4000 HEOR stakeholders that include policy makers, payers, thought leaders, researchers, decision makers, and representatives will gather in New Orleans to discuss the 2019 conference theme, "Rapid. Disruptive....
During ISPOR 2019, more than 4000 HEOR stakeholders that include policy makers, payers, thought leaders, researchers, decision makers, and representatives will gather in New Orleans to discuss the 2019 conference theme, "Rapid. Disruptive....
During ISPOR 2019, more than...
05/17/2019
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

May 2015 Volume 12 Issue 5

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use